$Exela Technologies (XELA.US)$ The market continues to decline.

$Aterian (ATER.US)$ will hit 15 next week

$PharmaCyte Biotech (PMCB.US)$
why turnover ratio so low? those major players have left this stock?

$Aterian (ATER.US)$
I will definitely buy more when it hits 7. should be soom

$PharmaCyte Biotech (PMCB.US)$ Sold. Pls drop to 2.5 to let me in again

$PharmaCyte Biotech (PMCB.US)$ up up up to the

$PharmaCyte Biotech (PMCB.US)$ up up to the

$PharmaCyte Biotech (PMCB.US)$ $Tilray Brands (TLRY.US)$ $Fate Therapeutics (FATE.US)$ One of the more notable companies to go public in August is PMCB, which owns the Cell-in-a-Box living Cell packaging platform for cancer and diabetes, and is developing cannabinoid-based drugs